BBC - Saturday, 14 October, 2000
Between 360 and 400 new patients are diagnosed with HIV every month in Malaysia, Associate Professor Adeeba Kamarulzaman, from the University of Malaya, told the gathering of medical experts in London.
Experts also warn the high costs of drugs used to treat sufferers' symptoms mean the majority of cases world-wide go untreated.
Less than 1% of sufferers in Thailand and only 10-20% of sufferers in Malaysia can afford treatment, a situation similar to that in Sub-Saharan Africa, which remains the world's worst affected area.
One in three people in Botswana suffer from HIV, and Zimbabwe is believed to have at least two million cases, of which 35% are pregnant women. High cost
The warnings came at the first 'HIV/Aids: A Commonwealth Emergency' conference at the Royal College of Physicians in central London.
The high cost of drugs needed to suppress the symptoms of HIV/Aids was highlighted as a key area for concern.
"Less than 1% of the Thai population have money left over for anti-retroviral treatment after food and non-food items," said Professor Kamarulzaman.
In Malaysia, 35,000 people have been diagnosed with HIV since the mid-1980s, but the cost of drugs mean only 10-20% of cases are being treated.
Further measures
The executive director of pharmaceutical company Glaxo Wellcome, James Cochrane, said that despite reductions in the price of drugs, further measures are urgently needed to fight the epidemic.
"The Ugandan government only spends ú4 ($5.9) per head per year on health. These drugs have to be subsidised if we are going to get people living longer," he said.
Professor Ahmed Latif from the University of Zimbabwe medical school also warned of poor morale among health workers, and the social impact of the Aids epidemic.
"Families are unable to cope with the situation they become poor and remain poor," he said.
"If a second person in the family becomes infected there is no more money left for them," he added.
The conference also heard that a vaccine for the disease remains at least five years away.
001014
BB001003
Copyright © 2000 - BBC. Reproduction of this article (other than one copy for personal reference) must be cleared through the BBC.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.